Brief: Alimera Sciences Reports First Quarter 2022 Results
09/05/2022 13:06
May 9 (Reuters) - Alimera Sciences Inc ALIM.O :
* ALIMERA SCIENCES REPORTS FIRST QUARTER 2022 RESULTS
* Q1 REVENUE ROSE 6 PERCENT TO $11.9 MILLION
* QTRLY NET LOSS PER SHARE - BASIC AND DILUTED $0.85
Source text for Eikon: ID:nGNXbP6Kyx
Further company coverage: ALIM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger